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Objective: To determine the occurrence of CTX-M producing Escherichia coli (E. coli)
from cattle feces in Bogor slaughterhouse, Indonesia.
Methods: A total of 220 cattle feces samples were collected from Bogor slaughterhouse
fromMarch toApril 2015. Presence of extended-spectrumbeta-lactamase (ESBL) producing
E. coli was detected by disc diffusion test based on the recommendation from Clinical and
Laboratory Standards Institute (2014). Bacterial strains which were conﬁrmed as producing
ESBLs were further analyzed for the presence of bla genes of the ESBL by PCR.
Results: The results showed that CTX-M producing E. coli isolates were detected in 19
samples from 220 samples (8.6%). The b-lactamase genes detected were CTX-M-1
(n = 10) and CTX-M-9 (n = 9). All of the CTX-M producing E. coli isolates showed
multidrug resistance phenotypes to at least four antibiotics. The highest incidence of an-
tibiotics resistance was showed to ampicillin (100.0%), cefotaxime (100.0%), and cef-
podoxime (100.0%), followed by streptomycin (84.3%), trimethoprim-sulfamethoxazole
(73.7%), erythromycin (52.6%), kanamycin (26.3%), doxycycline (10.5%), and ceftazi-
dime (0.0%).
Conclusions: Detection of CTX-M-producing E. coli in cattle feces raises important
questions as they can represent a potential risk factor to public health.1. Introduction
Escherichia coli (E. coli) belongs to the family of Enter-
obacteriaceae and is common in the gastrointestinal as normal
microﬂora in human and animals [1,2]. These bacteria have
capability to get and disseminate the resistant genes for
antibiotics [3–5]. One of the currently most important resistance
mechanisms is based on the plasmid-mediated production of
extended spectrum b-lactamases (ESBL) that inactivate thesecompounds by hydrolyzing their b-lactam ring [6,7]. Until now,
more than 600 ESBL variants are known. Among them, over 100
CTX-M enzymes so far reported may be grouped into ﬁve main
subgroups [8]. The CTX-M types of b-lactamases are dominant
family of ESBLs in E. coli, with particular subtypes associated
with different geographic regions [2]. As a matter of growing
concern, resistance caused by ESBLs is often associated with
resistance to other classes of antibiotics such as ﬂuoroquinolones,
aminoglycosides, and trimethoprim-sulfamethoxazole [8].
The dissemination of CTX-M E. coli in food production units
may occur via fecal cross-contamination between groups of
animals (or individuals), and the contamination of food derived
from animals may occur during processing in the slaughterhouse
[9]. Consequently, without good hygienic practices, foods may
act as a vehicle of transferring of b-lactam-resistant bacteria to
the gastrointestinal tract of the consumers [10]. This study was
aimed to determine the occurrence of CTX-M producing
E. coli from cattle feces in Bogor slaughterhouse, Indonesia.article under the CC BY-NC-ND license (http://
Table 1
Molecular characterization and antibiotic susceptibilities of ESBL pro-
ducing E. coli isolates.
Sample
code
bla genes Antibiotic resistance Total
CAZ CPD CTX STX AMP DO K SPT E R I S
44 CTX-M-9 S R R R R I I R R 6 2 1
45 CTX-M-1 S R R R R S R R R 7 0 2
62 CTX-M-1 S R R R R I S R S 5 1 3
65 CTX-M-1 S R R R R S S R S 5 0 4
66 CTX-M-1 S R R R R S S R S 5 0 4
67 CTX-M-9 S R R R R S S R S 5 0 4
69 CTX-M-1 S R R R R S R R R 7 0 2
79 CTX-M-1 S R R R R S S R R 6 0 3
80 CTX-M-1 S R R R R S I R S 5 1 3
87 CTX-M-1 S R R R R S I R R 6 1 2
88 CTX-M-1 S R R S R R S I S 4 1 4
89 CTX-M-9 S R R R R I R R R 7 1 1
91 CTX-M-9 S R R S R R I R R 6 1 2
100 CTX-M-9 S R R S R I S R R 5 1 3
101 CTX-M-9 S R R R R S I R S 5 1 3
104 CTX-M-9 S R R S R I S I R 4 2 3
107 CTX-M-1 S R R S R S I I R 4 2 3
115 CTX-M-9 S R R R R S R R S 6 0 3
119 CTX-M-9 S R R R R S R R S 6 0 3
CAZ: Ceftazidime; CPD: Cefpodoxime; CTX: Cefotaxime; STX:
Trimethoprim-sulfamethoxazole; AMP: Ampicillin; DO: Doxycycline;
K: Kanamycin; SPT: Streptomycin; E: Erythromycin; R: Resistant; I:
Intermediate; S: Susceptible.
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2.1. Isolation and identiﬁcation of ESBL producing
E. coli
A total of 220 fecal samples from Bogor slaughterhouse,
Indonesia were collected from March to April 2015. Each fecal
sample was collected directly from rectum. Fecal samples were
put in sterile plastic bags and transported to the laboratory using
cooling box. Fecal samples were rinsed in 0.1% buffered
peptone water (Oxoid CM1049, England). Rectum contents
(25 g) were diluted in 225 mL of 0.1% buffered peptone water.
Rinsates (10 mL) were enriched for 24 h at 37 C supplemented
with 20 mL cefotaxime (1 mg/mL). There after the enrichment
was streaked onto MacConkay agar (Merck 1.05465.0500,
Germany) containing 1 mg/L cefotaxime, and incubated at 37 C
for 24 h under aerobic condition. The colonies that ware pre-
sumed as E. coli will appear as red colonies in the media, and
surrounded by turbid zone. Further works were continued by
KOH test, Gram staining, oxidase test (Oxoid MB0266A, En-
gland), and biochemical test [indole, methyl red, Voges-
Proskauer, and citrate (IMViC)]. The colonies that were pre-
sumed as E. coli were selected and sub cultured onto tryptic soy
broth (Merck 1.05458.0500, Germany) at 37 C for 24 h. The
identiﬁcation of the E. coli-like colonies were then conﬁrmed
using API 20E (Biomerieux). Isolates were stored in tryptic soy
broth containing 20% glycerol at −20 C until further workup.
2.2. ESBL conﬁrmation and antibiotic susceptibility
testing
All cefotaxime-resistant, and oxidase-negative, isolates were
conﬁrmed for ESBL production by the disk diffusion method
according to the Clinical Laboratory Standards Institute (CLSI)
guidelines [11]. The inhibition zones were determined for each
isolate, using antibiotic disks, each containing 30 mg of
cefotaxime, ceftazidime, or cefpodoxime, either alone or in
combination with 10 mg of clavulanic acid (MAST Group
Ltd., Reinfeld, Germany).
E. coli isolates which produced ESBL were subjected to sus-
ceptibility testing against 9 antimicrobial agents (ampicillin,
cefotaxime, cefpodoxime, ceftazidime, streptomycin,
trimethoprim-sulfamethoxazole, erythromycin, kanamycin, and
doxycycline) with disk diffusion method according to CLSI pro-
tocols and evaluated with CLSI criteria [11]. E. coli ATCC 25922
and Klebsiella pneumoniae ATCC 700603 (K. pneumoniae)
were used as a control strain.
2.3. Characterization of b-lactamase by PCR
Bacterial strains which were conﬁrmed as producing ESBLs
were further analyzed for the presence of bla genes of the ESBL
subtypes TEM, SHV, and CTX-M (group 1, 2, 8, 9, or 25) by
PCR using primers and conditions as previously reported [12].
Bacterial DNA was isolated with the DNeasy blood and tissue
kit (Qiagen, Hilden, Germany) according to the manufacturer's
recommendations. Two strains, K. pneumoniae ATCC 700603
was used as standard ESBL-positive strains and a non-ESBL-
producing organism (E. coli ATCC 25922) was used as nega-
tive control. PCR products were determined by electrophoresis
in a 2% agarose gel (Biozym, Hessisch-Oldendorf, Germany).The molecular marker GeneRuler 100-bp DNA ladder (MBI
Fermentas, St. Leon-Roth, Germany) was used.
2.4. Sequencing of bla genes
The ESBL-encoding genes blaTEM, blaSHV, and blaCTX-M of
the ESBL-positive isolates were ampliﬁed with primers and PCR
conditions as described previously [12]. Resulting amplicons
were puriﬁed using the PCR puriﬁcation kit (Qiagen).
Sequencing was performed at SeqLab (Goettingen, Germany).
Results were evaluated using the BLAST algorithm available
at http://blast.ncbi.nlm.nih.gov/Blast.cgi.
2.5. Data analysis
Data were descriptively analyzed to describe occurrence of
CTX-M producing E. coli isolated from cattle feces in Bogor
slaughterhouse.
3. Results
In this present study, CTX-M producing E. coli was detected
in 19 samples from 220 samples (8.6%). The b-lactamase genes
detected were CTX-M-1 (n = 10) and CTX-M-9 (n = 9). All of
CTX-M producing E. coli isolates showed multidrug resistance
phenotypes to at least four antibiotics. The highest incidence of
antibiotics resistance was to ampicillin (100.0%), cefotaxime
(100.0%), and cefpodoxime (100.0%), followed by streptomycin
(84.3%), trimethoprim-sulfamethoxazole (73.7%), erythromycin
(52.6%), kanamycin (26.3%), doxycycline (10.5%), and cefta-
zidime (0.0%). Detail results on antibiotic susceptibilities of
multidrug resistant ESBL producing E. coli was described in
Table 1.
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The results showed that the occurrence of 8.6% of CTX-M-
producers in cattle feces was identiﬁed and blaCTX-M genes were
detected. In this study the CTX-M-1 (52.6%) and CTX-M-9
(47.4%) groups were reported as the most prevalent in ESBL-
producing E. coli isolates recovered from cattle feces samples.
This is the ﬁrst report of CTX-M producing E. coli in cattle
feces, in Indonesia.
A similar study in Portugal showed that CTX-resistant E. coli
isolates were detected in 5 of the 54 (9.3%) cattle feces samples
and CTX-M-1 enzyme was the most dominant ESBL type found
in E. coli cattle feces isolates [13]. Another study conducted in
Germany sought that the presence of ESBL producing E. coli
were detected in 17 of the 90 (18.9%) in cattle feces samples
and showed a high prevalence of CTX-M-1, CTX-M-2 and
CTX-M-9 ESBLs [14].
CTX-M b-lactamases are now the most prevalent type of
ESBL in most areas of the world, where the signiﬁcant increase
in the incidence of ESBL in Enterobacteriaceae has been
attributed to the dissemination of members of CTX-M-1 and
CTX-M-9 families of CTX-M enzymes [15]. The over 100 CTX-
M enzymes so far reported may be grouped into ﬁve main
subgroups [8]. The rapid proliferation and worldwide spread of
CTX-M-type ESBL in E. coli is a matter of concern both in
human and veterinary medicine [15]. Furthermore, it has been
reported that plasmids carrying CTX-M enzymes can transfer
these determinants to other commensal Enterobacteriaceae, such
as K. pneumoniae, or to pathogens like Shigella or Salmonella
spp. [7].
As a matter of growing concern, resistance caused by CTX-
M producer is often associated with resistance to other classes
of antibiotics like ﬂuoroquinolones, aminoglycosides, and
trimethoprim-sulfamethoxazole [6,8]. This study showed that all
of CTX-M producing E. coli exhibited multidrug resistance
phenotypes to at least four antibiotics. It is important to
emphasise that, often, some ESBL genes are located within
mobile genetic elements, associated with other resistance genes,
conferring resistance to antimicrobials that could be extensively
used among animals and humans (e.g., trimethoprim, sulfa-
methoxazole and streptomycin) and which could play an
important role in the co-selection of these ESBL genes [4].
CTX-M producing E. coli that was found in Bogor slaugh-
terhouse could release resistance genes to environment. Bacterial
contamination of the surface water, particularly contamination
with feces-borne bacteria, has long been a water quality
issue owing to the potential for disease transmission [16].
Slaughterhouse biosecurity must be increased to prevent
dissemination of ESBL producing E. coli to environment.
Moreover, vectors such as mice and ﬂies may also play a part
in the spread of antimicrobial resistance in farms [17].
It is estimated that ESBL producers will increase in future, in
both animals and humans [4]. Guidelines for alternative therapies,
monitoring programs, and development of preventive medicine
will decrease the spread of ESBLs in veterinary medicine.
Together, these strategies could certainly reduce the impact of
several multidrugs resistance microorganisms on animal health
[18].
In conclusion, CTX-M b-lactamases (8.6%) are the most
prevalent type of our ESBL-positive isolates and all of CTX-M
producing E. coli isolates showed multidrug resistance pheno-
types to at least four antibiotics. It could be threat for publichealth because CTX-M genes can be easily disseminate into the
environment, food, human, animals, and other pathogen bacteria.Conﬂict of interest statement
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